Join Bill Enright, Barinthus Biotherapeutics CEO and Bullfrog AI Board Member, and Carey class of 1995, for an overview of his work in the transition from science to business and taking a company public. 

This session is open to all candidates interested in Carey Business School and will showcase the great work that our alumni do on an everyday basis. Register here to join.